However, the finding that Smad3 protein is absent in T-cell acute lymphoblastic leukemia (T-ALL), which results in an impaired inhibitory effect of TGF-β on T-cell proliferation, supports the notion of a tumor-suppressing role of Smad3 in at least this disease. Here, SMAD3 is linked to neoplasm.